Third-party reimbursement for pharmacist instruction about antihemophilic factor

Am J Hosp Pharm. 1977 Aug;34(8):831-4.

Abstract

The trial and evaluation of pharmacy education program to teach a 14-year-old hemophiliac to self-administer Factor VIII at home is described. The home therapy program realized a cost saving of $20,230 for this patient for the first year; school attendance increased 15%. The results of the trial were used to justify a professional fee from Blue Cross of Central Ohio for the pharmacist's educational services.

MeSH terms

  • Adolescent
  • Blue Cross Blue Shield Insurance Plans
  • Factor VIII / administration & dosage*
  • Factor VIII / therapeutic use
  • Fees, Pharmaceutical
  • Hemophilia A / drug therapy
  • Home Care Services
  • Humans
  • Insurance, Pharmaceutical Services*
  • Male
  • Ohio
  • Patient Education as Topic*
  • Pharmacists*
  • Self Administration

Substances

  • Factor VIII